Table 1.
Baseline characteristics
| Cohort | DFT+ | DFT− | ||
|---|---|---|---|---|
|
| ||||
| Demographics | (n = 63) | (n = 40) | (n = 23) | p-value |
| Age (years) | 59.4 ± 13.6 | 55.9 ± 12.4 | 65.6 ± 13.7 | 0.007 |
| Number of males (%) | 41 (65) | 27 (68) | 14 (61) | 0.375 |
| Median LVEF (IQR) | 30.0 (21.8–35.0) | 28.8 (23.0–30.0) | 30.0 (21.3–50.0) | 0.255 |
| Number with ischemic etiology (%) | 35 (56) | 25 (63) | 10 (43) | 0.190 |
| Creatinine (mg/dL) | 1.04 ± 0.33 | 1.03 ± 0.29 | 1.06 ± 0.08 | 0.757 |
|
| ||||
| Implantation parameters | ||||
|
| ||||
| Screw deployments (number) | 2.9 ± 1.6 | 3.1 ±1.3 | 2.7±2.0 | 0.530 |
| Shocks per patient (number) | - | 1.6 ± 0.7 | n/a | - |
| Energy (J) | - | 33.1 ± 18.4 | n/a | - |
| Duration VF (sec) | - | 13 ± 3 | n/a | - |
| VF cycle length (ms) | - | 188 ± 23 | n/a | - |
Baseline characteristics of cohort and implantation parameters. VF (ventricular fibrillation).